| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/07/2011 | CN101474396B Pharmaceutical composition for treating rheumatism and atrophic arthritis |
| 09/07/2011 | CN101434657B Preparation and use of recombinant mtVEGF121/MAP30KDEL fusion noxioussubstance |
| 09/07/2011 | CN101407546B Human anti-human tumor necrosis factor-alpha single chain antibody |
| 09/07/2011 | CN101385784B Application of composition of daphniphyllum calycinum and ciderage for preparing drugs to prevent blockage syndrome |
| 09/07/2011 | CN101361868B Traditional Chinese medicine combination for treating rheumatism |
| 09/07/2011 | CN101327280B Chinese medicine for treating paralysis |
| 09/07/2011 | CN101234139B Proprietary Chinese medicine for curing common cold and preparation thereof |
| 09/07/2011 | CN101142225B Macrolides with anti-inflammatory activity |
| 09/07/2011 | CN101138594B Quality control method of traditional chinese medicine preparation for treating traumatic injury and rheumatism ostealgia |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8013016 Use of acetyl L-carnitine for the treatment of fibromyalgic syndrome |
| 09/06/2011 | US8012997 Isoindole-imide compounds, compositions, and uses thereof |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012995 Pharmaceutically active sulfonamide derivatives |
| 09/06/2011 | US8012934 Small peptides and methods for treatment of inflammation |
| 09/06/2011 | CA2684105C Pyridine derivatives |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/06/2011 | CA2415228C Treatment of bone diseases |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/06/2011 | CA2336361C Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/01/2011 | WO2011106729A2 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 09/01/2011 | WO2011106723A2 Anti-paf antibodies |
| 09/01/2011 | WO2011106688A1 Bis-fatty acid conjugates and their uses |
| 09/01/2011 | WO2011106248A2 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 09/01/2011 | WO2011105572A1 Novel heteroaryl derivative |
| 09/01/2011 | WO2011105424A1 Dendritic cell immunoreceptor stimulant |
| 09/01/2011 | WO2011105394A1 Method for producing regulatory dendritic cells |
| 09/01/2011 | WO2011104671A1 Novel water soluble furoxan derivatives having antitumor activity |
| 09/01/2011 | WO2011104584A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 09/01/2011 | WO2011104338A1 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | WO2011104337A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | WO2011104334A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | WO2011104309A1 Compounds for the treatment of inflammation and neutropenia |
| 09/01/2011 | WO2011104214A1 Silicon-containing biodegradable material for anti-inflammatory therapy |
| 09/01/2011 | WO2011104161A1 Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti - inflammatory agent for the treatment of inflammation and pain in the veterinary field |
| 09/01/2011 | WO2011103666A1 Modulation of cytokine-induced chronic inflammatory responses |
| 09/01/2011 | WO2010147792A3 Compounds which selectively modulate the cb2 receptor |
| 09/01/2011 | US20110214194 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway |
| 09/01/2011 | US20110213236 Therapeutic compositions, devices and methods for observing treated tissues |
| 09/01/2011 | US20110213037 Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213017 Targeted delivery of glycine receptors to excitable cells |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110213001 Pharmaceutical compositions |
| 09/01/2011 | US20110212992 Novel p2x7r antagonists and their use |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212962 P38 map kinase inhibitors |
| 09/01/2011 | US20110212952 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (vri) activity |
| 09/01/2011 | US20110212947 Substituted indole compounds having nos inhibitory activity |
| 09/01/2011 | US20110212945 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 09/01/2011 | US20110212943 Novel bridged cyclic compounds as histone deacetylase inhibitors |
| 09/01/2011 | US20110212941 Imidazoisoindole Neuropeptide S Receptor Antagonists |
| 09/01/2011 | US20110212940 S1P Receptor Modulating Compounds and Use Thereof |
| 09/01/2011 | US20110212933 Antiseptic Compositions for the Treatment of Infections |
| 09/01/2011 | US20110212927 Carbonate prodrugs and methods of using the same |
| 09/01/2011 | US20110212926 Water-soluble acetaminophen analogs |
| 09/01/2011 | US20110212925 Novel compounds as receptor modulators with therapeutic utility |
| 09/01/2011 | US20110212923 Phosphate Derivatives of Substituted Benzoxazoles |
| 09/01/2011 | US20110212916 Method and means for improving bowel health |
| 09/01/2011 | US20110212902 Metal-binding compounds and uses therefor |
| 09/01/2011 | US20110212900 Method for prophylactic and/or therapeutic treatment of pain associated with hematopoietic cell transplantation |
| 09/01/2011 | US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/01/2011 | US20110212883 Radical scavenger and active oxygen eliminating agent |
| 09/01/2011 | US20110212198 Hangover relief by compositions comprising oral rehydration solution |
| 09/01/2011 | US20110212180 Method of producing microcapsules |
| 09/01/2011 | US20110212172 Administration of an adsorbent polymer for treatment of systemic inflammation |
| 09/01/2011 | US20110212167 Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof |
| 09/01/2011 | US20110212155 Flexible, Compressed Intravaginal Rings, Methods of Making and Using the Same, and Apparatus for Making the Same |
| 09/01/2011 | US20110212112 Conformation specific antibodies |
| 09/01/2011 | US20110212111 MHC II Associated Protein and Uses Thereof |
| 09/01/2011 | US20110212104 Inflammatory bowel disease biomarkers and related methods of treatment |
| 09/01/2011 | US20110212103 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | US20110212102 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | US20110212100 Methods for modulating development and expansion of il-17 expressing cells |
| 09/01/2011 | US20110212099 Methods of modulating il-22 and il-17 |
| 09/01/2011 | US20110212097 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases |
| 09/01/2011 | US20110212096 Anti-p-selectin antibodies and methods of their use and identification |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212088 Anti-paf antibodies |
| 09/01/2011 | US20110212087 Antibody Fc Mutants with Ablated Effector Functions |
| 09/01/2011 | US20110212084 Binding members for ige molecules |
| 09/01/2011 | US20110212079 Adaptive biochemical signatures |
| 09/01/2011 | US20110212072 Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial Dysfunction |
| 09/01/2011 | US20110212069 Modulation of Microglia Activation |
| 09/01/2011 | US20110212053 Phosphatidylinositol 3 kinase inhibitors |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | US20110212050 Side-chain crystallizable polymers for medical applications |
| 09/01/2011 | US20110212047 Polymer Therapy for the Treatment of Chronic Microvascular Diseases |
| 09/01/2011 | CA2791105A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | CA2791103A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2,3-d] pyrimidines having mnk1/ mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | CA2790993A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 09/01/2011 | CA2790959A1 Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti-inflammatory agent for the treatment of inflammation and pain in the veterinary field |
| 09/01/2011 | CA2790922A1 Method for preparing regulatory dentritic cells |
| 09/01/2011 | CA2790818A1 Modulation of cytokine-induced chronic inflammatory responses |
| 09/01/2011 | CA2790646A1 Silicon-containing biodegradable material for anti-inflammatory therapy |
| 09/01/2011 | CA2790199A1 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 09/01/2011 | CA2788440A1 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 08/31/2011 | EP2362221A1 Antagonists of HMG1 for treating inflamatory conditions |
| 08/31/2011 | EP2361910A1 Compound having tafia inhibitory activity |